[Study on the clinical effectiveness of electronically stored nosodes from tooth diseases and articular rheumatism on persons with rheumatic diseases].
OBJECTIVE
For about 15 years, one of the authors (JS) has successfully treated patients suffering from rheumatic diseases with individually tested and electronically stored nosodes from tooth diseases and articular rheumatism using exogenic MORA bioresonance therapy. Until today no human study has tested that kind of nosode therapy. The present, partially controlled study aims to test the effectiveness of that type of nosode therapy.


METHODS
A partially placebo-controlled study was carried out on 15-21 participants (depending on the parameter) who suffered from rheumatic diseases. The main outcome parameter was the mean EAP(electro acupuncture)-40 value (controlled), i.e. the mean difference of the 40 final measured values from the norm of scale division 50. Secondary outcome parameters (not controlled) were the perceived state of health as well as biochemical, physicochemical and cellular parameters of the blood.


RESULTS
The mean EAP-40 value was significantly reduced (p < 0.01) by the verum treatment. The placebo treatment also yielded slight results but these were not significant (p > 0.05). The mean perceived state of health, the sedimentation of blood cells, the mean calcium value and the redox potential of the blood improved significantly (p < 0.01). The other parameters indicated no or only slight changes (p > 0.05).


CONCLUSIONS
The results suggest that therapy with electronically stored nosodes is effective in patients with rheumatic diseases.
Schuller
Johann
J
Zahnarztpraxis in Peggau/Ganzheitliche Medizin in Graz, Austria.
Galle
Michael
M
D000328:Adult; D000368:Aged; D001168:Arthritis / Q000628:therapy; D002908:Chronic Disease; D004599:Electric Stimulation Therapy / Q000379:methods*; D004574:Electromagnetic Fields; D004581:Electronics; D005260:Female; D006801:Humans; D008280:Magnetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012216:Rheumatic Diseases / Q000628:therapy*; D014076:Tooth Diseases / Q000628:therapy*; D016896:Treatment Outcome
D010919:Placebos